Business Wire (press release)

Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment …
Business Wire (press release)
In two single arm phase II studies of ADCETRIS, disease activity has been shown in the subtypes Sézary syndrome (SS), lymphomatoid papulosis (LyP) and mixed CTCL histology. These data suggest that efficacy and safety can be extrapolated to other CTCL …
AbbVie | LinkedInLinkedIn
Oncology – Therapeutic Focus Areas – Our Science | AbbVieAbbVie
AbbVie Careers – Home | FacebookFacebook
Instagram –PR Newswire
all 56 news articles »